Clinical Trials Browser

Phase 3 × INDUSTRY × oblimersen × Clear all

NCT00518895 2011-11-07

AGENDA

Phase 3 Completed

Melanoma, Skin Neoplasms

NCT00517218 2008-02-11

This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)

Phase 3 Withdrawn

Other hematologic neoplasm

Leukemia, Lymphoid